Answer
Yes, Ontozry (cenobamate) is contraindicated in people with familial Short-QT syndrome.
Sources for this answer
- Ontozry 200 mg film-coated tabletsAngelini Pharma UK-I Limited (Formerly Arvelle Therapeutics UK) · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked